These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 19414341
21. Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complex. Jayne S, Zwartjes CG, van Schaik FM, Timmers HT. Biochem J; 2006 Sep 15; 398(3):461-7. PubMed ID: 16712523 [Abstract] [Full Text] [Related]
22. Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer. Pathirage N, Di Nezza LA, Salmonsen LA, Jobling T, Simpson ER, Clyne CD. Fertil Steril; 2006 Aug 15; 86(2):469-72. PubMed ID: 16730717 [Abstract] [Full Text] [Related]
23. Down-regulation of bcl-2 is a potential marker of the efficacy of progestin therapy in the treatment of endometrial hyperplasia. Amezcua CA, Zheng W, Muderspach LI, Felix JC. Gynecol Oncol; 1999 Apr 15; 73(1):126-36. PubMed ID: 10094893 [Abstract] [Full Text] [Related]
24. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W. Gynecol Oncol; 2000 Nov 15; 79(2):169-76. PubMed ID: 11063639 [Abstract] [Full Text] [Related]
25. Expression of estrogen receptor coregulators in normal and malignant human endometrium. Kershah SM, Desouki MM, Koterba KL, Rowan BG. Gynecol Oncol; 2004 Jan 15; 92(1):304-13. PubMed ID: 14751175 [Abstract] [Full Text] [Related]
26. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator. Hudelist G, Czerwenka K, Kubista E, Marton E, Pischinger K, Singer CF. Breast Cancer Res Treat; 2003 Mar 15; 78(2):193-204. PubMed ID: 12725419 [Abstract] [Full Text] [Related]
27. The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer. Jones MB, Houwink AP, Freeman BK, Greenwood TM, Lafky JM, Lingle WL, Berchuck A, Maxwell GL, Podratz KC, Maihle NJ. J Soc Gynecol Investig; 2006 May 15; 13(4):304-11. PubMed ID: 16697948 [Abstract] [Full Text] [Related]
28. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models. Pennanen PT, Sarvilinna NS, Purmonen SR, Ylikomi TJ. Steroids; 2009 May 15; 74(4-5):404-9. PubMed ID: 19146866 [Abstract] [Full Text] [Related]
29. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation]. Sun PM, Wei LH, Gao M, Wang JL, Zhao LJ, Wang DP, Zhang JX. Zhonghua Fu Chan Ke Za Zhi; 2007 Jun 15; 42(6):408-11. PubMed ID: 17697604 [Abstract] [Full Text] [Related]
30. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Monge M, Colas E, Doll A, Gil-Moreno A, Castellvi J, Diaz B, Gonzalez M, Lopez-Lopez R, Xercavins J, Carreras R, Alameda F, Canals F, Gabrielli F, Reventos J, Abal M. Carcinogenesis; 2009 Aug 15; 30(8):1288-97. PubMed ID: 19443906 [Abstract] [Full Text] [Related]
31. Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness. Leite RS, Brown AG, Strauss JF. FASEB J; 2004 Sep 15; 18(12):1418-20. PubMed ID: 15231721 [Abstract] [Full Text] [Related]
32. Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex. Kelly SN, McKenna TJ, Young LS. J Endocrinol; 2005 Jul 15; 186(1):33-42. PubMed ID: 16002533 [Abstract] [Full Text] [Related]
33. Regulation of nuclear coactivator and corepressor expression in mouse cerebellum by thyroid hormone. Ramos HE, Weiss RE. Thyroid; 2006 Mar 15; 16(3):211-6. PubMed ID: 16571082 [Abstract] [Full Text] [Related]
34. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Wagner BL, Norris JD, Knotts TA, Weigel NL, McDonnell DP. Mol Cell Biol; 1998 Mar 15; 18(3):1369-78. PubMed ID: 9488452 [Abstract] [Full Text] [Related]
35. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells. Sarvilinna N, Eronen H, Miettinen S, Vienonen A, Ylikomi T. Int J Cancer; 2006 Feb 15; 118(4):832-40. PubMed ID: 16152593 [Abstract] [Full Text] [Related]
36. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells. Purmonen S, Manninen T, Pennanen P, Ylikomi T. Oncol Rep; 2008 Jun 15; 19(6):1627-34. PubMed ID: 18497975 [Abstract] [Full Text] [Related]
37. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mönckedieck V, Sannecke C, Husen B, Kumbartski M, Kimmig R, Tötsch M, Winterhager E, Grümmer R. Mol Hum Reprod; 2009 Oct 15; 15(10):633-43. PubMed ID: 19671596 [Abstract] [Full Text] [Related]
38. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch. Bhatti SF, Rao NA, Okkens AC, Mol JA, Duchateau L, Ducatelle R, van den Ingh TS, Tshamala M, Van Ham LM, Coryn M, Rijnberk A, Kooistra HS. Domest Anim Endocrinol; 2007 Oct 15; 33(3):294-312. PubMed ID: 16956744 [Abstract] [Full Text] [Related]
39. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells. Saegusa M, Hashimura M, Kuwata T, Hamano M, Watanabe J, Kawaguchi M, Okayasu I. J Pathol; 2008 Dec 15; 216(4):521-32. PubMed ID: 18798221 [Abstract] [Full Text] [Related]